Rights and permissions
About this article
Cite this article
No alteration in the standard basiliximab dosing regimen is necessary in any particular patient subpopulation to prevent renal transplant rejection. Inpharma Wkly. 1220, 18 (2000). https://doi.org/10.2165/00128413-200012200-00047
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012200-00047